Td: Clinical Trials

5 trials of Td, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5
Phase 31Completed 1

Follow Td: new trials by email Literature Review of Td trials Research Report on Td

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
pp65-shLAMP DC with GM-CSF, unpulsed PBMC and saline, Td - Glioblastoma Multiforme, Glioblastoma
Phase 2CompletedUniversity of Florida1752016-08-092025-01-14
Maternal Tdap Immunization in Guatemala
Tdap, Td - Pertussis, Whooping Cough
Phase 2CompletedEmory University2862016-07-012019-10-16
DC Migration Study for Newly-Diagnosed GBM
Unpulsed DCs, Td, Human CMV pp65-LAMP mRNA-pulsed autologous DCs - Glioblastoma, Astrocytoma, Grade IV
Phase 2CompletedMustafa Khasraw, MBChB, MD, FRCP, FRACP642015-10-122023-06-08
Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis.
dimethyl fumarate, tetanus diphtheria toxoids vaccine, 23-valent pneumococcal polysaccharide vaccine - Relapsing Forms of Multiple Sclerosis
Phase 2CompletedBiogen712015-02-282017-06-02
Pertussis Maternal Immunization Study
Tdap, Td - Pregnant Women
Phase 2 / Phase 3CompletedScott Halperin3202007-11-012020-08-27

Conditions studied

Glioblastoma (2)  ·  Whooping Cough (2)  ·  Glioma (1)

Sponsors

Biogen (1)  ·  Emory University (1)  ·  Mustafa Khasraw, MBChB, MD, FRCP, FRACP (1)  ·  Scott Halperin (1)  ·  University of Florida (1)

Countries

United States (3)  ·  Canada (1)  ·  Guatemala (1)

Top investigators

Dina Randazzo, DO (1)  ·  Duane Mitchell, MD, PhD (1)  ·  Maryam Rahman, MD (1)  ·  Saad B. Omer, MBBS,MPH,PhD (1)  ·  Scott A Halperin, MD (1)

Results publications

PMID 29159204, PMID 30010773, PMID 38461048

NIH funding

R01CA175517 (1)